Timegadine

DB19656ExperimentalSmall molecule

Timegadine is a small molecule drug. Timegadine has a monoisotopic molecular weight of 365.17 Da.

Mechanism: Pharmacologically active on Polyunsaturated fatty acid 5-lipoxygenase and Human Cyclooxygenases
Curator reviewed
Formula / weight: C₂₀H₂₃N₅S · 365.5 g/mol (avg)
Code names: SR-1368

Resolves to

Compound

Structure

InChIKeySQVNITZYWXMWOG-UHFFFAOYSA-NSMILESCC1=NC2=CC=CC=C2C(N\C(NC2=NC=CS2)=N/C2CCCCC2)=C1

Targets

What you can answer from here — as of September 21, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Timegadine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.